Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103935756 | 10393575 | 6 | F | 20130212 | 20160810 | 20140819 | 20160810 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-21299235 | BRISTOL MYERS SQUIBB | 32.61 | YR | M | Y | 0.00000 | 20160810 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103935756 | 10393575 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | SINGLE DOSE | U | 21436 | 156 | MG | TABLET | ||||||
| 103935756 | 10393575 | 2 | SS | NORTRIPTYLINE HCL | NORTRIPTYLINE HYDROCHLORIDE | 1 | Oral | 600 MG, UNK | U | 0 | 600 | MG | |||||||
| 103935756 | 10393575 | 3 | SS | DULOXETINE HCL | DULOXETINE HYDROCHLORIDE | 1 | Oral | 1710 MG, UNK | U | 0 | 1710 | MG | |||||||
| 103935756 | 10393575 | 4 | C | BIPERIDEN HCL | BIPERIDEN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 103935756 | 10393575 | 5 | C | CLOXAZOLAM | CLOXAZOLAM | 1 | Unknown | U | 0 | ||||||||||
| 103935756 | 10393575 | 6 | C | TRIAZOLAM. | TRIAZOLAM | 1 | Unknown | U | 0 | ||||||||||
| 103935756 | 10393575 | 7 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103935756 | 10393575 | 1 | Product used for unknown indication |
| 103935756 | 10393575 | 2 | Product used for unknown indication |
| 103935756 | 10393575 | 3 | Product used for unknown indication |
| 103935756 | 10393575 | 4 | Product used for unknown indication |
| 103935756 | 10393575 | 5 | Product used for unknown indication |
| 103935756 | 10393575 | 6 | Product used for unknown indication |
| 103935756 | 10393575 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103935756 | 10393575 | HO |
| 103935756 | 10393575 | OT |
| 103935756 | 10393575 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103935756 | 10393575 | Altered state of consciousness | |
| 103935756 | 10393575 | Obstructive airways disorder | |
| 103935756 | 10393575 | Overdose | |
| 103935756 | 10393575 | Pneumonia aspiration | |
| 103935756 | 10393575 | Ventricular arrhythmia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103935756 | 10393575 | 1 | 20130212 | 20130212 | 0 | |
| 103935756 | 10393575 | 2 | 20130212 | 20130212 | 0 | |
| 103935756 | 10393575 | 3 | 20130212 | 20130212 | 0 |